{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:18:35Z","timestamp":1772119115044,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["A-11627"],"award-info":[{"award-number":["A-11627"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1229721N"],"award-info":[{"award-number":["1229721N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-025-02621-1","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:37:48Z","timestamp":1766065068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical evaluation of [11C]CHDI-009R for quantification of mutant huntingtin aggregates"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5410-687X","authenticated-orcid":false,"given":"Franziska","family":"Zajicek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5985-1609","authenticated-orcid":false,"given":"Liesbeth","family":"Everix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6488-5456","authenticated-orcid":false,"given":"Annemie","family":"Van Eetveldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4493-1902","authenticated-orcid":false,"given":"Jeroen","family":"Verhaeghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5307-3575","authenticated-orcid":false,"given":"Stef","family":"De Lombaerde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5381-015X","authenticated-orcid":false,"given":"Alan","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1533-9504","authenticated-orcid":false,"given":"Jordy","family":"Akkermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2175-5117","authenticated-orcid":false,"given":"Vinod","family":"Khetarpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5097-1361","authenticated-orcid":false,"given":"Jonathan","family":"Bard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3995-0196","authenticated-orcid":false,"given":"Longbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3376-0519","authenticated-orcid":false,"given":"Steven","family":"Staelens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4205-5432","authenticated-orcid":false,"given":"Daniele","family":"Bertoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"issue":"5","key":"2621_CR1","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S (2016) The biology of Huntingtin. Neuron 89(5):910\u2013926","journal-title":"Neuron"},{"issue":"6","key":"2621_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The-Huntington\u2019s-Disease-Collaborative-Research-Group","year":"1993","unstructured":"The-Huntington\u2019s-Disease-Collaborative-Research-Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72(6):971\u2013983","journal-title":"Cell"},{"issue":"1","key":"2621_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334","journal-title":"Eur J Neurol"},{"key":"2621_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/7854_2014_354","volume":"22","author":"HJ Waldvogel","year":"2015","unstructured":"Waldvogel HJ, Kim EH, Tippett LJ, Vonsattel JP, Faull RL (2015) The neuropathology of Huntington\u2019s disease. Curr Top Behav Neurosci 22:33\u201380","journal-title":"Curr Top Behav Neurosci"},{"issue":"5","key":"2621_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","volume":"101","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi SJ, Ghosh R, Leavitt BR (2019) Huntingtin lowering strategies for disease modification in Huntington\u2019s disease. Neuron 101(5):801\u2013819","journal-title":"Neuron"},{"issue":"10","key":"2621_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","volume":"16","author":"EJ Wild","year":"2017","unstructured":"Wild EJ, Tabrizi SJ (2017) Therapies targeting DNA and RNA in Huntington\u2019s disease. Lancet Neurol 16(10):837\u2013847","journal-title":"Lancet Neurol"},{"issue":"8","key":"2621_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11910-024-01345-y","volume":"24","author":"J Saade","year":"2024","unstructured":"Saade J, Mestre TA (2024) Huntington\u2019s disease: latest frontiers in therapeutics. Curr Neurol Neurosci Rep 24(8):255\u2013264","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2621_CR8","doi-asserted-by":"publisher","first-page":"105652","DOI":"10.1016\/j.nbd.2022.105652","volume":"166","author":"NS Caron","year":"2022","unstructured":"Caron NS, Banos R, Aly AE, Xie Y, Ko S, Potluri N, Anderson C, Black HF, Anderson LM, Gordon B et al (2022) Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice. Neurobiol Dis 166:105652","journal-title":"Neurobiol Dis"},{"issue":"6","key":"2621_CR9","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA, Artates JW, Weiss A, Cheng SH, Shihabuddin LS et al (2012) Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis. Neuron 74(6):1031\u20131044","journal-title":"Neuron"},{"issue":"630","key":"2621_CR10","doi-asserted-by":"publisher","first-page":"eabm3682","DOI":"10.1126\/scitranslmed.abm3682","volume":"14","author":"D Bertoglio","year":"2022","unstructured":"Bertoglio D, Bard J, Hessmann M, Liu L, Gartner A, De Lombaerde S, Huscher B, Zajicek F, Miranda A, Peters F et al (2022) Development of a ligand for in vivo imaging of mutant huntingtin in Huntington\u2019s disease. Sci Transl Med 14(630):eabm3682","journal-title":"Sci Transl Med"},{"issue":"4","key":"2621_CR11","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s00259-021-05578-8","volume":"49","author":"D Bertoglio","year":"2022","unstructured":"Bertoglio D, Verhaeghe J, Miranda A, Wyffels L, Stroobants S, Mrzljak L, Khetarpal V, Skinbjerg M, Liu L, Dominguez C, Munoz-Sanjuan I, Bard J, Staelens S (2022) Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington\u2019s disease. Eur J Nucl Med Mol Imaging 49(4):1166\u20131175","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2621_CR12","doi-asserted-by":"publisher","first-page":"17977","DOI":"10.1038\/s41598-021-97334-z","volume":"11","author":"F Herrmann","year":"2021","unstructured":"Herrmann F, Hessmann M, Schaertl S, Berg-Rosseburg K, Brown CJ, Bursow G, Chiki A, Ebneth A, Gehrmann M, Hoeschen N, Hotze M, Jahn S, Johnson PD, Khetarpal V, Kiselyov A, Kottig K, Ladewig S, Lashuel H, Letschert S, Mills MR, Petersen K, Prime ME, Scheich C, Schmiedel G, Wityak J, Liu L, Dominguez C, Munoz-Sanjuan I, Bard JA (2021) Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates. Sci Rep 11(1):17977","journal-title":"Sci Rep"},{"issue":"16","key":"2621_CR13","doi-asserted-by":"publisher","first-page":"12003","DOI":"10.1021\/acs.jmedchem.1c00667","volume":"64","author":"L Liu","year":"2021","unstructured":"Liu L, Johnson PD, Prime ME, Khetarpal V, Lee MR, Brown CJ, Chen X, Clark-Frew D, Coe S, Conlon M, Davis R, Ensor S, Esposito S, Moren AF, Gai X, Green S, Greenaway C, Haber J, Halldin C, Hayes S, Herbst T, Herrmann F, Hessmann M, Hsai MM, Kotey A, Mangette JE, Mills MR, Monteagudo E, Nag S, Nibbio M, Orsatti L, Schaertl S, Scheich C, Sproston J, Stepanov V, Varnas K, Varrone A, Wityak J, Mrzljak L, Munoz-Sanjuan I, Bard JA, Dominguez C (2021) [(11)C]CHDI-626, a PET tracer candidate for imaging mutant huntingtin aggregates with reduced binding to AD pathological proteins. J Med Chem 64(16):12003\u201312021","journal-title":"J Med Chem"},{"issue":"10","key":"2621_CR14","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.2967\/jnumed.123.265569","volume":"64","author":"D Bertoglio","year":"2023","unstructured":"Bertoglio D, Weiss AR, Liguore W, Martin LD, Hobbs T, Templon J, Srinivasan S, Dominguez C, Munoz-Sanjuan I, Khetarpal V, Verhaeghe J, Staelens S, Link J, Liu L, Bard JA, McBride JL (2023) In vivo cerebral imaging of mutant Huntingtin aggregates using (11)C-CHDI-180R PET in a nonhuman primate model of Huntington Disease. J Nucl Med 64(10):1581\u20131587","journal-title":"J Nucl Med"},{"issue":"15","key":"2621_CR15","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1021\/acs.jmedchem.0c00955","volume":"63","author":"L Liu","year":"2020","unstructured":"Liu L, Prime ME, Lee MR, Khetarpal V, Brown CJ, Johnson PD, Miranda-Azpiazu P, Chen X, Clark-Frew D, Coe S, Davis R, Dickie A, Ebneth A, Esposito S, Gadouleau E, Gai X, Galan S, Green S, Greenaway C, Giles P, Halldin C, Hayes S, Herbst T, Herrmann F, Hessmann M, Jia Z, Kiselyov A, Kotey A, Krulle T, Mangette JE, Marston RW, Menta S, Mills MR, Monteagudo E, Nag S, Nibbio M, Orsatti L, Schaertl S, Scheich C, Sproston J, Stepanov V, Svedberg M, Takano A, Taylor M, Thomas W, Toth M, Vaidya D, Vanras K, Weddell D, Wigginton I, Wityak J, Mrzljak L, Munoz-Sanjuan I, Bard JA, Dominguez C (2020) Imaging mutant Huntingtin aggregates: development of a potential PET ligand. J Med Chem 63(15):8608\u20138633","journal-title":"J Med Chem"},{"issue":"1","key":"2621_CR16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1021\/acs.jmedchem.2c01585","volume":"66","author":"L Liu","year":"2023","unstructured":"Liu L, Johnson PD, Prime ME, Khetarpal V, Brown CJ, Anzillotti L, Bertoglio D, Chen X, Coe S, Davis R et al (2023) Design and evaluation of [(18)F]CHDI-650 as a positron emission tomography ligand to image mutant Huntingtin aggregates. J Med Chem 66(1):641\u2013656","journal-title":"J Med Chem"},{"issue":"1","key":"2621_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00259-024-06880-x","volume":"52","author":"F Zajicek","year":"2024","unstructured":"Zajicek F, Verhaeghe J, De Lombaerde S, Van Eetveldt A, Miranda A, Munoz-Sanjuan I, Dominguez C, Khetarpal V, Bard J, Liu L et al (2024) Preclinical evaluation of the novel [(18)F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington\u2019s disease. Eur J Nucl Med Mol Imaging 52(1):122\u2013133","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2621_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00259-022-05945-z","volume":"50","author":"A Delva","year":"2022","unstructured":"Delva A, Koole M, Serdons K, Bormans G, Liu L, Bard J, Khetarpal V, Dominguez C, Munoz-Sanjuan I, Wood A, Skinbjerg M, Wang Y, Vandenberghe W, Van Laere K (2022) Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [(11)C]CHDI-00485180-R and [(11)C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin. Eur J Nucl Med Mol Imaging 50(1):48\u201360","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2621_CR19","doi-asserted-by":"crossref","unstructured":"Delva A, Koole M, Serdons K, Bormans G, Skinbjerg M, Khetarpal V, Liu L, Bard J, Doot R, Warner JH, Sathe S, Sampaio C, Wood A, Van Laere K, Vandenberghe W (2025) PET imaging with [(1)(1)C]CHDI-00485180-R, designed as radioligand for aggregated mutant huntingtin, in people with Huntington's disease. Eur J Nucl Med Mol Imaging\u00a052(13):5124\u20135134","DOI":"10.1007\/s00259-025-07394-w"},{"issue":"14","key":"2621_CR20","doi-asserted-by":"publisher","first-page":"14818","DOI":"10.1021\/acs.jmedchem.5c01005","volume":"68","author":"L Liu","year":"2025","unstructured":"Liu L, Johnson PD, Mills MR, Turner PA, Prime ME, Brown CJ, Kotey A, Coe S, Giles PR, Lloyd C et al (2025) Isoindolinone-based PET tracers for imaging mutant huntingtin aggregates. J Med Chem 68(14):14818\u201314842","journal-title":"J Med Chem"},{"issue":"12","key":"2621_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio W, McConnell K, Connor D, Murphy C, Oakeshott S, Kwan M, Beltran J, Ghavami A, Brunner D, Park LC, Ramboz S, Howland D (2012) Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE 7(12):e49838","journal-title":"PLoS ONE"},{"issue":"12","key":"2621_CR22","doi-asserted-by":"publisher","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen T, Lehtimaki K, Vartiainen N, Puolivali J, Hendricks SJ, Glaser JR, Bradaia A, Wadel K, Touller C, Kontkanen O et al (2012) Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS ONE 7(12):e50717","journal-title":"PLoS ONE"},{"issue":"7","key":"2621_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069782","volume":"8","author":"C Cudalbu","year":"2013","unstructured":"Cudalbu C, McLin VA, Lei H, Duarte JM, Rougemont AL, Oldani G, Terraz S, Toso C, Gruetter R (2013) The C57BL\/6J mouse exhibits sporadic congenital portosystemic shunts. PLoS ONE 8(7):e69782","journal-title":"PLoS ONE"},{"issue":"6","key":"2621_CR24","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1177\/0271678X19864081","volume":"40","author":"D Bertoglio","year":"2020","unstructured":"Bertoglio D, Verhaeghe J, Miranda A, Kertesz I, Cybulska K, Korat S, Wyffels L, Stroobants S, Mrzljak L, Dominguez C et al (2020) Validation and noninvasive kinetic modeling of [(11)C]UCB-J PET imaging in mice. J Cereb Blood Flow Metab 40(6):1351\u20131362","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"2621_CR25","doi-asserted-by":"publisher","DOI":"10.1088\/2057-1976\/ab8c13","volume":"6","author":"A Miranda","year":"2020","unstructured":"Miranda A, Bertoglio D, Glorie D, Stroobants S, Staelens S, Verhaeghe J (2020) Validation of a spatially variant resolution model for small animal brain PET studies. Biomed Phys Eng Express 6(4):045001","journal-title":"Biomed Phys Eng Express"},{"issue":"10","key":"2621_CR26","doi-asserted-by":"publisher","first-page":"e0206613","DOI":"10.1371\/journal.pone.0206613","volume":"13","author":"D Bertoglio","year":"2018","unstructured":"Bertoglio D, Verhaeghe J, Kosten L, Thomae D, Van der Linden A, Stroobants S, Wityak J, Dominguez C, Mrzljak L, Staelens S (2018) MR-based spatial normalization improves [18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington\u2019s disease. PLoS ONE 13(10):e0206613","journal-title":"PLoS ONE"},{"issue":"2","key":"2621_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.neuroimage.2010.06.067","volume":"53","author":"GA Johnson","year":"2010","unstructured":"Johnson GA, Badea A, Brandenburg J, Cofer G, Fubara B, Liu S, Nissanov J (2010) Waxholm space: an image-based reference for coordinating mouse brain research. Neuroimage 53(2):365\u2013372","journal-title":"Neuroimage"},{"issue":"4","key":"2621_CR28","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s11307-019-01435-1","volume":"22","author":"D Bertoglio","year":"2020","unstructured":"Bertoglio D, Verhaeghe J, Korat S, Miranda A, Wyffels L, Stroobants S, Mrzljak L, Dominguez C, Liu L, Skinbjerg M et al (2020) In vitro and in vivo assessment of suitable reference region and kinetic modelling for the mGluR1 radioligand [(11)C]ITDM in mice. Mol Imaging Biol 22(4):854\u2013863","journal-title":"Mol Imaging Biol"},{"issue":"10","key":"2621_CR29","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1177\/0271678X221101648","volume":"42","author":"D Bertoglio","year":"2022","unstructured":"Bertoglio D, Zajicek F, Lombaerde S, Miranda A, Stroobants S, Wang Y, Dominguez C, Munoz-Sanjuan I, Bard J, Liu L et al (2022) Validation, kinetic modeling, and test-retest reproducibility of [(18)F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice. J Cereb Blood Flow Metab 42(10):1867\u20131878","journal-title":"J Cereb Blood Flow Metab"},{"key":"2621_CR30","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/fneur.2018.00516","volume":"9","author":"J Verhaeghe","year":"2018","unstructured":"Verhaeghe J, Bertoglio D, Kosten L, Thomae D, Verhoye M, Van Der Linden A, Wyffels L, Stroobants S, Wityak J, Dominguez C, Mrzljak L, Staelens S (2018) Noninvasive relative quantification of [(11)C]ABP688 PET imaging in mice versus an input function measured over an arteriovenous shunt. Front Neurol 9:516","journal-title":"Front Neurol"},{"key":"2621_CR31","unstructured":"Paxinos G, Franklin KBJ (2003) The mouse brain in stereotaxic coordinates, 2nd edn. Academic Press"},{"issue":"2","key":"2621_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/WCO.0000000000001035","volume":"35","author":"G Cassinelli Petersen","year":"2022","unstructured":"Cassinelli Petersen G, Roytman M, Chiang GC, Li Y, Gordon ML, Franceschi AM (2022) Overview of tau PET molecular imaging. Curr Opin Neurol 35(2):230\u2013239","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"2621_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1037\/1040-3590.6.4.284","volume":"6","author":"D Cicchetti","year":"1994","unstructured":"Cicchetti D (1994) Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 6(4):284\u2013290","journal-title":"Psychol Assess"},{"key":"2621_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106906","volume":"209","author":"DM Marchionini","year":"2025","unstructured":"Marchionini DM, De Lombaerde S, van Rijswijk J, Zajicek F, Everix L, Miranda A, Aaltonen MJ, Kluger CM, Wild T, Kakoulidou A, Gundelach J, Fieblinger T, Fentz J, Rosinski J, Obenauer J, Greene JR, Liu L, Munoz-Sanjuan I, Verhoye M, Verhaeghe J, Bard J, Staelens S, Bertoglio D (2025) Pharmacodynamic biomarkers responsive to mutant huntingtin lowering in a Huntington\u2019s disease mouse model. Neurobiol Dis 209:106906","journal-title":"Neurobiol Dis"},{"key":"2621_CR35","doi-asserted-by":"crossref","unstructured":"Weiss AR, Liguore WA, Brandon K, Wang X, Liu Z, Domire JS, Button D, Srinivasan S, Kroenke CD, McBride JL (2022) A novel rhesus macaque model of Huntington\u2019s disease recapitulates key neuropathological changes along with motor and cognitive decline. Elife 11:e77568","DOI":"10.7554\/eLife.77568"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02621-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02621-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02621-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:37:50Z","timestamp":1766065070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02621-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2621"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02621-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6820127\/v1","asserted-by":"object"}]},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experiments followed the European Committee (decree 2010\/63\/CEE) and were approved by the Ethical Committee for Animal Testing (ECD 2019\u201339) at the University of Antwerp (Belgium).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This work was funded by CHDI Foundation, Inc., a privately-funded nonprofit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that improve the lives of those affected by Huntington\u2019s disease. CD, VK, JB, and LL are employed by CHDI Management, Inc., the company that manages the scientific activities of CHDI Foundation. No other potential conflicts of interest relevant to this article exist.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}